ScandiDos ABOSTO:SDOS +0.60%47 FCF Margin % is -13.73% as of Apr. 2026. GuruFocus rates OSTO:SDOS with a GF Score™ of 47/100 and a GF Value™ of kr1.15 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 815 Medical Devices & Instruments companies, ScandiDos AB ranks worse than 67.85% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. ScandiDos AB's Free Cash Flow for the
three
months ended in Apr. 2026 was kr-1.94 Mil. ScandiDos AB's Revenue for the
three
months ended in Apr. 2026 was kr14.15 Mil. Therefore, ScandiDos AB's FCF Margin % for the quarter that ended in Apr. 2026 was -13.73%.
The historical rank and industry rank for ScandiDos AB's FCF Margin % or its related term are showing as below:
OSTO:SDOS'
s FCF Margin % Range Over the Past 10 Years
Min: -44.87 Med: -16.18 Max: 6.81
Current: -12.8
During the past 13 years, the highest FCF Margin % of ScandiDos AB was 6.81%. The lowest was -44.87%. And the median was -16.18%.
OSTO:SDOS's FCF Margin % is ranked worse than 67.85% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.1
vs OSTO:SDOS: -12.80
ScandiDos AB FCF Margin % Related Terms
ScandiDos AB FCF Margin % Historical Data
* Premium members only.
The historical data trend for ScandiDos AB's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:SDOS vs ABT, SYK, MDT: FCF Margin % Comparison
For the Medical Devices subindustry, ScandiDos AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ScandiDos AB FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ScandiDos AB's FCF Margin % distribution charts can be found below:
* The bar in red indicates where ScandiDos AB's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ScandiDos AB (OSTO:SDOS) has a FCF Margin % of -13.73% as of Apr. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on ScandiDos AB and its competitors. According to the industry distribution chart, ScandiDos AB ranks #553 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 67.9%.
Is ScandiDos AB's FCF Margin % too high?
ScandiDos AB's current FCF Margin % is -13.73%. Based on the distribution chart, ScandiDos AB ranks #553 out of 815 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, ScandiDos AB has a GF Score™ of 47/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ScandiDos AB's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, ScandiDos AB ranks #553 out of 815 companies for FCF Margin %. This places ScandiDos AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on ScandiDos AB and its competitors. ScandiDos AB's current FCF Margin % is -13.73%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ScandiDos AB stock overvalued right now?
Based on GuruFocus' analysis, ScandiDos AB (OSTO:SDOS) is currently considered Modestly Undervalued. The stock's GF Value™ is kr1.15, compared to a current price of kr0.84 — trading 27.4% below its estimated fair value. The current FCF Margin % is -13.73%. ScandiDos AB's overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For ScandiDos AB (OSTO:SDOS), the current FCF Margin % is -13.73% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ScandiDos AB (OSTO:SDOS) Overvalued in 2026?
Based on GuruFocus' analysis, ScandiDos AB stock appears to be undervalued.
The current stock price of kr0.84 is trading 27.4% below its estimated GF Value™ of kr1.15.
GuruFocus considers ScandiDos AB to be Modestly Undervalued.
Key valuation signals for OSTO:SDOS:
FCF Margin %: -13.73%
GF Value™: kr1.15 vs. price of kr0.84 (27.4% below fair value)
No single metric tells the full story. See the OSTO:SDOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ScandiDos AB is engaged in providing radiation therapy for cancer. Its product, Delta4 Phantom+, and its various hardware and software options are at the heart of everything ScandiDos does, from product development and production to marketing, sales, and customer support. With Delta4 HexaMotion ScandiDos has successfully developed a motion platform that recreates the movement of the tumor in six dimensions and independently simulates the patient's breathing movement.
47GF Score
Get the complete analysis for OSTO:SDOS
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:SDOS has been successfully added to your 
